Cambridge, MA and Lyon, September 6, 2021 – ERYTECH Pharma, a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, announced that its CEO, Gil Beyen, will present at the H.C. Wainwright 23rd Annual Global Investment Conference.
September 6, 2021
· 3 min read